Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.02.IsomAb secures funds to advance peripheral arterial disease treatment
20.02.Everest Medicines to terminate deal with Providence for mRNA platform
19.02.FDA grants breakthrough therapy status for Otsuka's IgAN drug
16.02.Japan grants priority review for Astellas' urothelial cancer regimen
15.02.Atara submits IND application to FDA for CAR T-cell therapy
14.02.ProfoundBio secures $112m to advance ADC portfolio for cancer
13.02.Precision receives payments from TG Therapeutics for azer-cel
12.02.FDA grants orphan drug designation for Disc's PV treatment
09.02.Aizon secures funds to accelerate development pipeline
08.02.Samsung Biologics and LegoChem enter ADC development deal
07.02.NIH grants $9m for nicotine cessation drug development
06.02.Exicure and Bluejay sign hepatitis treatment development deal
05.02.Zuellig Pharma acquires Cialis and Alimta brands from Lilly
02.02.US FDA grants orphan drug status for Rznomics' HCC treatment
01.02.Sandoz launches Tyruko in Germany for treatment of adults with RRMS
31.01.US FDA grants ODD to NeoImmuneTech's NT-I7 for pancreatic cancer treatment
30.01.Oricell's OriCAR-017 application secures FDA IND clearance
29.01.EMA validates Pfizer-Astellas' bladder cancer therapy application for review
26.01.Entos opens GMP clinical manufacturing facility in US
25.01.UroGen submits new drug application to FDA for UGN-102
24.01.BlueRock exercises option to license cell therapy candidate
23.01.ASTCT, ACCC and AACI launch initiative for CAR T therapy
22.01.Zokinvy gets Japanese approval for Progeria treatment
19.01.Kindeva Drug Delivery acquires Summit Biosciences
18.01.Eurofins Alphora completes Canadian biologics development facility